These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 7682488
1. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]. Palazzuoli V, Mondillo S, Faglia S, D'Aprile N, Camporeale A, Gennari C. Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488 [Abstract] [Full Text] [Related]
2. [Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine]. Mondillo S, Faglia S, D'Aprile N, Mangiacotti L, Campolo MA, Agricola E, Palazzuoli V. Clin Ter; 1995 Dec; 146(12):769-74. PubMed ID: 8681496 [Abstract] [Full Text] [Related]
3. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone]. Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H. Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720 [Abstract] [Full Text] [Related]
4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F. Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741 [Abstract] [Full Text] [Related]
5. [Anti-arrhythmia treatment using L-carnitine in acute myocardial infarct]. Martina B, Zuber M, Weiss P, Burkart F, Ritz R. Schweiz Med Wochenschr; 1992 Sep 12; 122(37):1352-5. PubMed ID: 1384117 [Abstract] [Full Text] [Related]
6. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL. Minerva Cardioangiol; 1995 Oct 12; 43(10):449-57. PubMed ID: 8819814 [Abstract] [Full Text] [Related]
7. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function]. Saitta A, Bonaiuto M, Mileto A, Oriti S, Cinquegrani M, Giordano G, Fodale P, Saitta M, Squadrito F. Clin Ter; 1993 Apr 12; 142(4):351-60. PubMed ID: 8330479 [Abstract] [Full Text] [Related]
8. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Huguet R, Wajman A. Arch Mal Coeur Vaiss; 1986 Sep 12; 79(10):1495-505. PubMed ID: 2432845 [Abstract] [Full Text] [Related]
9. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P. G Ital Cardiol; 1986 Apr 12; 16(4):328-32. PubMed ID: 2427383 [Abstract] [Full Text] [Related]
10. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]. Klempt HW, Nayebagha A, Fabry E. Z Kardiol; 1982 May 12; 71(5):340-9. PubMed ID: 6180562 [Abstract] [Full Text] [Related]
11. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients. Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B. Ren Fail; 2005 May 12; 27(4):367-72. PubMed ID: 16060121 [Abstract] [Full Text] [Related]
12. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy]. Sarubbi B, Ducceschi V, Briglia N, Esposito R, Mayer MS, Scialdone A, Santangelo L, Iacono A. Cardiologia; 1996 Jul 12; 41(7):645-51. PubMed ID: 8983831 [Abstract] [Full Text] [Related]
13. [Clinical trial of propafenone (rytmonorm) in arrhythmia of patients with ischemic heart disease)]. Dobrotvorskaia TE, Koroleva ON, Gordina OV, Marakanova AV. Klin Med (Mosk); 1996 Jul 12; 74(3):51-3. PubMed ID: 8926706 [No Abstract] [Full Text] [Related]
14. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms]. Mastropasqua F, Totaro P, Massari F, Pitzalis MV, Rizzon P. Cardiologia; 1998 Jun 12; 43(6):617-23. PubMed ID: 9675961 [Abstract] [Full Text] [Related]
15. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level]. Lachnit KS, Rieder L. Z Gerontol; 1985 Jun 12; 18(6):343-52. PubMed ID: 2420079 [Abstract] [Full Text] [Related]
16. [The efficacy of propaphenol in extrasystole in patients with ischemic heart disease]. Dobrotvorskaia TE, Rybakova MK, Suprun EK, Arifullin ShS. Ter Arkh; 1992 Jun 12; 64(12):30-2. PubMed ID: 1284005 [No Abstract] [Full Text] [Related]
17. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial. Sanna G, Meoli P, Bianchini C, Rovelli F. G Ital Cardiol; 1983 Jun 12; 13(3):145-51. PubMed ID: 6350090 [Abstract] [Full Text] [Related]
18. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure. Ghidini O, Azzurro M, Vita G, Sartori G. Int J Clin Pharmacol Ther Toxicol; 1988 Apr 12; 26(4):217-20. PubMed ID: 3403101 [Abstract] [Full Text] [Related]
19. Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential. Gao E, Yang C, Li H, Duan Y, Zhou Y. Chin Med J (Engl); 1997 Sep 12; 110(9):723-5. PubMed ID: 9642335 [Abstract] [Full Text] [Related]
20. [The circadian profile of ventricular extrasystole]. Paisana JP, Gomes F, Cruz J, Bonhorst D, Lopes D, Schneider V, Bruges G, Gil C. Rev Port Cardiol; 1993 Jan 12; 12(1):7-8, 23-32. PubMed ID: 7686016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]